Skip to main content
Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
26.74
+0.03 (0.11%)
At close: Nov 5, 2024, 4:00 PM
26.59
-0.15 (-0.56%)
After-hours: Nov 5, 2024, 4:04 PM EST

Galapagos NV Revenue

Galapagos NV had revenue of 59.85M EUR in the quarter ending September 30, 2024, a decrease of -50.14%. This brings the company's revenue in the last twelve months to 260.09M, down -52.19% year-over-year. In the year 2023, Galapagos NV had annual revenue of 239.72M, down -0.63%.

Revenue (ttm)
260.09M EUR
Revenue Growth
-52.19%
P/S Ratio
n/a
Revenue / Employee
231,606 EUR
Employees
1,123
Market Cap
1.78B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023239.72M-1.53M-0.63%
Dec 31, 2022241.25M6.87M2.93%
Dec 31, 2021234.38M-243.67M-50.97%
Dec 31, 2020478.05M-356.85M-42.74%
Dec 31, 2019834.90M517.06M162.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeoGenomics 628.25M
NovoCure 577.74M
BioCryst Pharmaceuticals 382.24M
Beam Therapeutics 352.57M
Tarsus Pharmaceuticals 83.37M
Nurix Therapeutics 56.42M
Recursion Pharmaceuticals 49.64M
Celldex Therapeutics 8.30M
Revenue Rankings

GLPG News

More News